Abstract
In cancer patients, surveillance aims to identify curable recurrent disease after treatment. In patients with a premalignant condition, surveillance is performed to identify progression of the disease and to allow for intervention prior to malignant transformation.
Surveillance intervals and procedures vary for the different organs of the gastrointestinal tract and are addressed separately in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Recommended Reading
https://radiopaedia.org/articles/fukuoka-consensus-guidelines-1.
Kastelein F, et al. Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett’s esophagus. Clin Gastroenterol Hepatol. 2013;11:382.
Neumann H, et al. Cancer risk in IBD: How to diagnose and how to manage DALM and ALM. World J Gastroenterol. 2011;17:3184–91.
Pita-Fernandez S, et al. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2015;26:644.
Renehan AG, O’Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow-up after curative resection for colorectal cancer. BMJ. 2004;328:81.
UpTo Date®: Barrett’s esophagus: Surveillance and management.
UpTo Date®: Biliary cysts.
UpTo Date®: Classification of pancreatic cysts.
UpTo Date®: Epidemiology and nonfamilial risk factors for exocrine pancreatic cancer.
UpTo Date®: Familial adenomatous polyposis: Screening and management of patients and families.
UpTo Date®: Gastric intestinal metaplasia.
UpTo Date®: Gastric polyps.
UpTo Date®: Hepatic adenoma.
UpToDate®: Intraductal papillary mucinous neoplasm of the pancreas (IPPM): Evaluation and management
UpTo Date®: Large gastric folds: Hyperplastic and nonhyperplastic gastropathies.
UpTo Date®: Overview of colon polyps.
UpTo Date®: Solid liver lesions: Differential diagnosis and evaluation.
UpTo Date®: Surveillance after colorectal cancer resection.
UpTo Date®: Surveillance and management of dysplasia in patients with inflammatory bowel disease.
Waddel T, et al. Gastric cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. EJSO. 2014;40:584–91.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Wichmann, M.W., McCullough, T.K. (2019). Surveillance and Premalignant Conditions. In: Wichmann, M., McCullough, T., Roberts-Thomson, I., Maddern, G. (eds) Gastroenterology For General Surgeons. Springer, Cham. https://doi.org/10.1007/978-3-319-92768-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-92768-8_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92767-1
Online ISBN: 978-3-319-92768-8
eBook Packages: MedicineMedicine (R0)